Recent Events & Catalysts
West Pharmaceutical Services (WST) — real, dated facts. Not a claim about what caused any single day's price move.
Committee Signals
Proprietary signals generated by the Innellis AI committee — score changes, rating shifts, and analyst disagreements.
Score Change2d ago
WST committee score fell 2.9 points
WST's Committee score moved from 62.72 to 59.78 (-2.94, 1 day(s) apart).
Agreement Shift2d ago
WST analyst agreement shifted
WST's Committee agreement moved from 57.10% to 42.90% (-14.20pp, 1 day(s) apart).
Score Change12d ago
WST committee score fell 1.1 points
WST's Committee score moved from 63.28 to 62.15 (-1.13, 1 day(s) apart).
Rating Change13d ago
WST: Watch → Buy
WST moved from Watch to Buy (1 day(s) apart).
Agreement Shift13d ago
WST analyst agreement shifted
WST's Committee agreement moved from 71.40% to 57.10% (-14.30pp, 1 day(s) apart).
Score Change13d ago
WST committee score rose 3.5 points
WST's Committee score moved from 59.75 to 63.28 (+3.53, 1 day(s) apart).
News
Best Dividend Aristocrats For August 2026
SeekingAlpha · today
GEHC Q2 Earnings & Revenues Beat Estimates, Stock Up in Pre-Market
Yahoo · today
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now
Yahoo · today
Bio-Techne's Q4 Earnings on Deck: What's in Store for the Stock?
Yahoo · today
STERIS' Q1 Earnings on Deck: What's in Store for the Stock?
Yahoo · 1d ago
MMED Gets Medicare Coverage for Flex and Broadens Diabetes Care Access
Yahoo · 2d ago
Here's How IDEXX Laboratories Is Placed Ahead of Q2 Earnings
Yahoo · 2d ago
Beat the Market Like Zacks: Monster Beverage, Carpenter Tech, Usio in Focus
Yahoo · 2d ago
SEC Filings (90 days)
Results of operations (earnings release), Regulation FD disclosure, Financial statements and exhibits
Filed 2026-07-23 · 7d ago · Material
Entry into a material agreement, Financial statements and exhibits
Filed 2026-07-14 · 16d ago
Departure/appointment of directors or officers, Regulation FD disclosure, Financial statements and exhibits
Filed 2026-06-01 · 59d ago
Item 1.05, Financial statements and exhibits
Filed 2026-05-20 · 71d ago
Item 1.05, Regulation FD disclosure, Financial statements and exhibits
Filed 2026-05-11 · 80d ago
Earnings
No recent earnings data available.
Latest Analyst Action
No recent analyst actions available.